Intervention Protocol

You have free access to this content

Protease inhibitors in combination with pegylated interferon and ribavirin for adult patients with chronic hepatitis C virus

  1. Mohammed Eyad Yaseen AlSabbagh1,*,
  2. Perica Davitkov2,
  3. Yngve Falck-Ytter3

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 18 JUN 2013

Assessed as up-to-date: 15 MAY 2013

DOI: 10.1002/14651858.CD010587


How to Cite

Yaseen AlSabbagh ME, Davitkov P, Falck-Ytter Y. Protease inhibitors in combination with pegylated interferon and ribavirin for adult patients with chronic hepatitis C virus (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD010587. DOI: 10.1002/14651858.CD010587.

Author Information

  1. 1

    Case Western Reserve University, Internal Medicine Departement, 3rd floor, Cleveland, OH, USA

  2. 2

    Case Western Reserve University, 4th floor, Cleveland, OH, USA

  3. 3

    VA Medical Center, Division of Gastroenterology, Cleveland, OH, USA

*Mohammed Eyad Yaseen AlSabbagh, Internal Medicine Departement, 3rd floor, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH, 44106, USA. eyadsbg@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 18 JUN 2013

SEARCH

References

Additional references

Benvegnu 2001
Brok 2010
Egger 1997
Fattovich 2002
  • Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E. European Concerted Action on Viral Hepatitis (EUROHEP). Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. American Journal of Gastroenterology 2002;97(11):288-95.
    Direct Link:
Foster 2009
  • Foster G, Uddin G, Dias A. Hepatitis C virus. In: Mahtab MA, Rahman S editor(s). Liver. A Complete Book on Hepato-Pancreato-Biliary Diseases. Elsevier. Health Sciences Education, 2009:229-44.
Fried 2002
  • Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. New England Journal of Medicine 2002;347(13):975-82.
Ghany 2009
Gluud 2007
Gluud 2013
  • Gluud C, Nikolova D, Klingenberg SL, Alexakis N, Als-Nielsen B, Colli A, et al. Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2013, Issue 5. Art. No.: LIVER.
Guyatt 2011
  • Guyatt G, Oxman AD, Kunz R, Brozek J, Alonso-Coello PA, Rind D. GRADE guideline 6. Rating the quality of evidence - imprecision. Journal of Clinical Epidemiology 2011;64(12):1283-93.
Hofmann 2011
  • Hofmann WP, Zeuzem S. A new standard of care for the treatment of chronic HCV infection. Nature Reviews. Gastroenterology & Hepatology 2011;8:257–64.
Hollis 1999
Hoofnagle 2006
ICH-GCP 1997
  • International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice 1997 CFR & ICH Guidelines. Vol. 1, PA 19063-2043, USA: Barnett International/PAREXEL, 1997.
Kjaergard 2001
Klingenberg 2011
Koretz 2013
Lundh 2012
McGovern 2008
Moher 1998
  • Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
Morgan 2013
  • Morgan RL, Baack B, Smith B, Yartel A, Pitasi M, Falck-Ytter Y. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma. Annals of Internal Medicine 2013;158:329-37.
OPTN 2005
  • Organ Procurement and Transplantation Network (OPTN). OPTN/SRTR Annual Report. Chapter VI ; Liver and Intestine Transplantation in the United States, 1995-2004. http://www.ustransplant.org/annual_reports/current/ar_archives.htm (accessed 5 January 2012).
RevMan 2012
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Royle 2003
  • Royle P, Milne R. Literature searching for randomised controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003; Vol. 19, issue 4:591-603.
Savović 2012a
  • Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine 2012;157:429-38.
Savović 2012b
  • Savović J, Jones HE, Altman DG, Harris RJ, Jűni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment 2012;16(35):1-82.
Schulz 1995
  • Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
Seeff 2002
Seeff 2009
Simmonds 1993
  • Simmonds P, Chan SW. Analysis of viral sequence variation by PCR. In: Davison AJ, Elliott RM editor(s). Molecular Virology: A Practical Approach. Oxford: IRL Press, 1993:109-38.
Strader 2004
Thompson 2002
WHO 2011
  • WHO. Hepatitis C. Fact sheet N°164. http://www.who.int/mediacentre/factsheets/fs164/en/ 2011 (accessed 6 June 2013).
Wood 2008
  • Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Ed.) 2008;336:601-5.